Skip to main content
Erschienen in: Herz 6/2020

01.10.2018 | Original articles

Clinical outcomes after tricuspid surgery

The role of previous cardiac surgery

verfasst von: J. Rodríguez-Capitán, MD, V. M. Becerra-Muñoz, PhD, B. Pérez-Villardón, MD, G. Sánchez-Espín, MD, M. Such-Martínez, MD, A. Flores-Marín, PhD, I. Fernández-Pérez, PhD, A. García-Bellón, MD, C. Porras-Martín, MD, M. J. Mataró-López, PhD, J. M. Melero-Tejedor, PhD, E. Rodríguez-Caulo, MD, J. J. Otero-Forero, MD, A. Cordero-Aguilar, PhD, R. López-Salguero, PhD, J. J. Gómez-Doblas, MD, E. de Teresa-Galván, MD

Erschienen in: Herz | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

The aim of our study was to assess the outcomes of surgical treatment for severe tricuspid regurgitation according to whether cardiac surgery had been performed before the tricuspid valve intervention.

Methods

Between 1996 and 2013, 201 consecutive patients with severe tricuspid regurgitation underwent tricuspid surgery at our center. Patients were classified according to whether or not they had undergone previous cardiac surgery, which 33% of the sample had. Perioperative as well as long-term morbidity and mortality were analyzed.

Results

Mean patient age was 62.3 years. 32.8% underwent suture annuloplasty, 41.3% underwent ring annuloplasty, 15.4% received a bioprosthesis, and 10.4% received a mechanical prosthesis. There were no significant differences in perioperative mortality between the group that had not undergone previous cardiac surgery and the group that had (12.7% vs. 17.9%, respectively; = 0.32). The long-term mortality rate (median follow-up time: 53 months) was 43.3%. Long-term survival curves showed no significant differences between the two groups (= 0.884), and previous cardiac surgery was not a predictive factor for long-term mortality (hazard ratio = 1.211; = 0.521).

Conclusion

In a series of patients who underwent tricuspid valve surgery, no significant differences were observed in perioperative mortality or in long-term survival according to whether or not subjects had undergone previous cardiac surgery.
Literatur
1.
Zurück zum Zitat Topilsky Y, Khanna AD, Oh JK et al (2011) Preoperative factors associated with adverse outcome after tricuspid valve replacement. Circulation 123:1929–1939CrossRef Topilsky Y, Khanna AD, Oh JK et al (2011) Preoperative factors associated with adverse outcome after tricuspid valve replacement. Circulation 123:1929–1939CrossRef
2.
Zurück zum Zitat Baumgartner H, Falk V, Bax JJ, ESC Scientific Document Group et al (2017) 2017 ESC/EACTS Guidelines for the management of valvular heart disease: The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 38:2739–91.CrossRef Baumgartner H, Falk V, Bax JJ, ESC Scientific Document Group et al (2017) 2017 ESC/EACTS Guidelines for the management of valvular heart disease: The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 38:2739–91.CrossRef
3.
Zurück zum Zitat Zoghbi WA, Enriquez-Sarano M, Foster E et al (2003) Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16:777–802CrossRef Zoghbi WA, Enriquez-Sarano M, Foster E et al (2003) Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16:777–802CrossRef
4.
Zurück zum Zitat Umehara N, Miyata H, Motomura N, Saito S, Yamazaki K (2014) Surgical results of reoperative tricuspid surgery: analysis from the Japan Cardiovascular Surgery Database. Interact Cardiovasc Thorac Surg 19:82–87CrossRef Umehara N, Miyata H, Motomura N, Saito S, Yamazaki K (2014) Surgical results of reoperative tricuspid surgery: analysis from the Japan Cardiovascular Surgery Database. Interact Cardiovasc Thorac Surg 19:82–87CrossRef
5.
Zurück zum Zitat Lange R, Piazza N, Günther T (2017) Tricuspid valve regurgitation: indications and operative techniques. Herz 42:653–661CrossRef Lange R, Piazza N, Günther T (2017) Tricuspid valve regurgitation: indications and operative techniques. Herz 42:653–661CrossRef
6.
Zurück zum Zitat Marquis-Gravel G, Bouchard D, Perrault LP et al (2012) Retrospective cohort analysis of 926 tricuspid valve surgeries: clinical and hemodynamic outcomes with propensity score analysis. Am Heart J 163:851–858CrossRef Marquis-Gravel G, Bouchard D, Perrault LP et al (2012) Retrospective cohort analysis of 926 tricuspid valve surgeries: clinical and hemodynamic outcomes with propensity score analysis. Am Heart J 163:851–858CrossRef
7.
Zurück zum Zitat Mao B, Sun L, Zhang J, Zhou M, Zhang F (2016) Perioperative factors associated with short- and long-term outcomes after tricuspid valve replacement. Interact Cardiovasc Thorac Surg 23:845–850CrossRef Mao B, Sun L, Zhang J, Zhou M, Zhang F (2016) Perioperative factors associated with short- and long-term outcomes after tricuspid valve replacement. Interact Cardiovasc Thorac Surg 23:845–850CrossRef
8.
Zurück zum Zitat Ratnatunga CP, Edwards MB, Dore CJ, Taylor KM (1998) Tricuspid valve replacement: UK Heart Valve Registry mid-term results comparing mechanical and biological prostheses. Ann Thorac Surg 66:1940–1947CrossRef Ratnatunga CP, Edwards MB, Dore CJ, Taylor KM (1998) Tricuspid valve replacement: UK Heart Valve Registry mid-term results comparing mechanical and biological prostheses. Ann Thorac Surg 66:1940–1947CrossRef
9.
Zurück zum Zitat McGrath LB, Gonzalez-Lavin L, Bailey BM, Grunkemeier GL, Fernandez J, Laub GW (1990) Tricuspid valve operations in 530 patients. Twenty-five-year assessment of early and late phase events. J Thorac Cardiovasc Surg 99:124–133CrossRef McGrath LB, Gonzalez-Lavin L, Bailey BM, Grunkemeier GL, Fernandez J, Laub GW (1990) Tricuspid valve operations in 530 patients. Twenty-five-year assessment of early and late phase events. J Thorac Cardiovasc Surg 99:124–133CrossRef
10.
Zurück zum Zitat Gatti G, Dell’Angela L, Morosin M et al (2016) Flexible band versus rigid ring annuloplasty for functional tricuspid regurgitation: two different patterns of right heart reverse remodelling. Interact Cardiovasc Thorac Surg 23:79–89CrossRef Gatti G, Dell’Angela L, Morosin M et al (2016) Flexible band versus rigid ring annuloplasty for functional tricuspid regurgitation: two different patterns of right heart reverse remodelling. Interact Cardiovasc Thorac Surg 23:79–89CrossRef
11.
Zurück zum Zitat Hornick P, Harris PA, Taylor KM (1996) Tricuspid valve replacement subsequent to previous open heart surgery. J Heart Valve Dis 5:20–25PubMed Hornick P, Harris PA, Taylor KM (1996) Tricuspid valve replacement subsequent to previous open heart surgery. J Heart Valve Dis 5:20–25PubMed
12.
Zurück zum Zitat King RM, Schaff HV, Danielson GK et al (1984) Surgery for tricuspid regurgitation late after mitral valve replacement. Circulation 70:I193–97PubMed King RM, Schaff HV, Danielson GK et al (1984) Surgery for tricuspid regurgitation late after mitral valve replacement. Circulation 70:I193–97PubMed
13.
Zurück zum Zitat Fukunaga N, Okada Y, Konishi Y, Murashita T, Koyama T (2014) Persistent tricuspid regurgitation after tricuspid annuloplasty during redo valve surgery affects late survival and valve-related events. Circ J 78:2696–2703CrossRef Fukunaga N, Okada Y, Konishi Y, Murashita T, Koyama T (2014) Persistent tricuspid regurgitation after tricuspid annuloplasty during redo valve surgery affects late survival and valve-related events. Circ J 78:2696–2703CrossRef
14.
Zurück zum Zitat Jeong DS, Park PW, Mwambu TP et al (2013) Tricuspid reoperation after left-sided rheumatic valve operations. Ann Thorac Surg 95:2007–2013CrossRef Jeong DS, Park PW, Mwambu TP et al (2013) Tricuspid reoperation after left-sided rheumatic valve operations. Ann Thorac Surg 95:2007–2013CrossRef
15.
Zurück zum Zitat Park CK, Park PW, Sung K, Lee YT, Kim WS, Jun TG (2009) Early and midterm outcomes for tricuspid valve surgery after left-sided valve surgery. Ann Thorac Surg 88:1216–1223CrossRef Park CK, Park PW, Sung K, Lee YT, Kim WS, Jun TG (2009) Early and midterm outcomes for tricuspid valve surgery after left-sided valve surgery. Ann Thorac Surg 88:1216–1223CrossRef
16.
Zurück zum Zitat Nishimura RA, Otto CM, Bonow RO et al (2014) ACC/AHA Task Force Members. 2014 AHA/ACC. Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129:2440–2492CrossRef Nishimura RA, Otto CM, Bonow RO et al (2014) ACC/AHA Task Force Members. 2014 AHA/ACC. Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129:2440–2492CrossRef
17.
Zurück zum Zitat Topilsky Y, Nkomo VT, Vatury O et al (2014) Clinical outcome of isolated tricuspid regurgitation. JACC Cardiovasc Imaging 7:1185–1194CrossRef Topilsky Y, Nkomo VT, Vatury O et al (2014) Clinical outcome of isolated tricuspid regurgitation. JACC Cardiovasc Imaging 7:1185–1194CrossRef
18.
Zurück zum Zitat Tang GH, David TE, Singh SK, Maganti MD, Armstrong S, Borger MA (2006) Tricuspid valve repair with an annuloplasty ring results in improved long-term outcomes. Circulation 114:I577–81CrossRef Tang GH, David TE, Singh SK, Maganti MD, Armstrong S, Borger MA (2006) Tricuspid valve repair with an annuloplasty ring results in improved long-term outcomes. Circulation 114:I577–81CrossRef
Metadaten
Titel
Clinical outcomes after tricuspid surgery
The role of previous cardiac surgery
verfasst von
J. Rodríguez-Capitán, MD
V. M. Becerra-Muñoz, PhD
B. Pérez-Villardón, MD
G. Sánchez-Espín, MD
M. Such-Martínez, MD
A. Flores-Marín, PhD
I. Fernández-Pérez, PhD
A. García-Bellón, MD
C. Porras-Martín, MD
M. J. Mataró-López, PhD
J. M. Melero-Tejedor, PhD
E. Rodríguez-Caulo, MD
J. J. Otero-Forero, MD
A. Cordero-Aguilar, PhD
R. López-Salguero, PhD
J. J. Gómez-Doblas, MD
E. de Teresa-Galván, MD
Publikationsdatum
01.10.2018
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 6/2020
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-018-4761-8

Weitere Artikel der Ausgabe 6/2020

Herz 6/2020 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.